Hochschulschrift
Novel p53-targeting therapeutic approaches for the treatment of high-risk ependymoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
105 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Ruprecht-Karls-Universität Heidelberg, Dissertation, 2016
- Classification
-
Medizin, Gesundheit
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:25 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting high-risk pediatric brain tumor entities
Targeting liposarcoma by various therapeutic approaches with concurrent exploitation of genetic aberrations
Therapeutic strategies targeting Kv10.1 in PDAC
Exploring mutant p53 targeting strategies for cancer therapy
Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis
Targeting p53 and its domains for cancer gene therapy
Targeting MDM2, the antagonist of the tumor suppressor p53
Targeting p53 and its domains for cancer gene therapy
Targeting the TRAF6-Ubc13 interaction for therapeutic intervention
New Therapeutic Approaches in Pulmonary Embolism
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting high-risk pediatric brain tumor entities
Targeting liposarcoma by various therapeutic approaches with concurrent exploitation of genetic aberrations
Therapeutic strategies targeting Kv10.1 in PDAC
Exploring mutant p53 targeting strategies for cancer therapy
Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis
Targeting p53 and its domains for cancer gene therapy
Targeting MDM2, the antagonist of the tumor suppressor p53
Targeting p53 and its domains for cancer gene therapy
Targeting the TRAF6-Ubc13 interaction for therapeutic intervention
New Therapeutic Approaches in Pulmonary Embolism
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting high-risk pediatric brain tumor entities
Targeting liposarcoma by various therapeutic approaches with concurrent exploitation of genetic aberrations
Therapeutic strategies targeting Kv10.1 in PDAC
Exploring mutant p53 targeting strategies for cancer therapy
Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis
Targeting p53 and its domains for cancer gene therapy
Targeting MDM2, the antagonist of the tumor suppressor p53
Targeting p53 and its domains for cancer gene therapy
Targeting the TRAF6-Ubc13 interaction for therapeutic intervention